DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018310
NDA 018310 describes LYMPHAZURIN, which is a drug marketed by Covidien and is included in one NDA. It is available from one supplier. Additional details are available on the LYMPHAZURIN profile page.
The generic ingredient in LYMPHAZURIN is isosulfan blue. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.
The generic ingredient in LYMPHAZURIN is isosulfan blue. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.
Summary for 018310
| Tradename: | LYMPHAZURIN |
| Applicant: | Covidien |
| Ingredient: | isosulfan blue |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 018310
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LYMPHAZURIN | isosulfan blue | INJECTABLE;INJECTION | 018310 | NDA | UNITED STATES SURGICAL CORPORATION | 63261-250 | E | 63261-250-21 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
